• Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • Telegram
  • Youtube
  • otv

Tag: Covaxin

Covaxin
Covaxin Shows 50% Effectiveness Against Symptomatic COVID-19 In Real-World Assessment: Lancet Study

The research was conducted during the peak of India's second wave of COVID-19 with high test positivity rates for both hospital employees and residents of Delhi, they said.

COVID Vaccine
Nepal, India to recognise Covid vax certification

An MoU was signed to recognise Covid-19 vaccine certification by India's Ambassador to Nepal Vinay Mohan Kwatra and the Himalayan nation's Health Secretary on Tuesday.

110 Countries Recognise India's Covishield, Covaxin: Source
110 Countries Recognise India's Covishield, Covaxin: Source

Of eight WHO-approved vaccines against Covid-19 in emergency use listing, two vaccines -- Covaxin and Covishield -- are from India.

 Covaxin
Covaxin 77.8% Effective Against COVID-19: Lancet study

The phase 3 trial Efficacy and Safety Study involving 25,800 volunteers across 25 sites in India is India's largest ever clinical trial conducted for a Covid-19 vaccine.

Covaxin
UK To Add India's Covaxin To Approved List From November 22

Covishield, the India-manufactured Oxford-AstraZeneca COVID-19 vaccine, was added to the UK's approved list last month.

Bharat Biotech's US Partner Ocugen Seeks Covaxin Approval For Kids
Bharat Biotech's US Partner Ocugen Seeks Covaxin Approval For Kids

Covaxin uses the same Vero Cell manufacturing platform as other childhood vaccines, including the inactivated polio vaccine.

Finally Approved!
Covaxin Gets WHO Nod; Union Health Minister’s Reaction

Covaxin Gets WHO Nod; Union Health Minister’s Reaction

Video Icon
Bharat Biotech's Covaxin
Bharat Biotech's Covaxin gets WHO's nod

The World Health Organisation (WHO) granted Emergency Use Listing approval to India's indigenously-developed Covid vaccine, Bharat Biotech's Covaxin on Wednesday.

Covaxin
CDSCO approves extension of Covaxin's shelf life to 12 months

India's drug regulator, the Central Drugs Standards Control Organisation (CDSCO) has approved the extension of shelf life of indigenously-developed Covid-19 vaccine Covaxin from nine to 12 months.

Covaxin
After Australia, 5 More Countries Recognise India's Covaxin

Five more countries on Monday recognised India's vaccine certificate, after Australia recognised Bharat Biotech's Covaxin for allowing entry of travellers who had received the vaccine

Covaxin
Australia Recognises India's Covaxin

This recognition is for travellers aged 12 and over who have been vaccinated with Covaxin, and those 18 to 60 who have been vaccinated with BBIBP-CorV.

WHO Body Seeks More Clarification To Decide On Covaxin EUL
WHO Body Seeks More Clarification To Decide On Covaxin EUL

Hyderabad based Bharat Biotech is expected to submit the data by this weekend.

Bharat Biotech's Covaxin
WHO May Approve Bharat Biotech's Covaxin Within 24 Hours

The Hyderabad-based Bharat Biotech had applied to the WHO on April 19 for Covaxin's Emergency Use Listing

COVID-19 Vaccine
Don't Cast Doubt On Vaccination: SC Junks Plea Against Mass Vax Of Covishield, Covaxin

The top court told the petitioner's counsel that it finds no error with the high court decision in the matter, and it will not entertain the petition.

WHO To Meet Next Week To Consider Emergency Use Listing Of India's Covaxin
WHO To Meet Next Week To Consider Emergency Use Listing Of India's Covaxin

Bharat Biotech recently said it has submitted all data pertaining to Covaxin to the WHO for the EUL and is awaiting feedback from the global health watchdog.

Covaxin Approved
Finally, Covaxin Approved For Children In 2-18 Yrs Age Group, DCGI Gives Nod

The Drugs and Comptroller General of India (DCGI) has given a go-ahead to Bharat Biotech's Covaxin for vaccination of children in the 2-18 years age group.

Video Icon
 Covaxin
Covaxin Approved For Children In 2-18 Age Group

The Subject Expert Committee (SEC) has given the necessary approval for the administration of the anti-Covid vaccine to children.

Covaxin or Covishield?
No Difference In Covaxin & Covishield Antibodies: Top Odisha Health Offical

There is no difference in antibodies produced by Covaxin and Covishield vaccines against the Covid-19 virus. This information was shared by Odisha Health Services Director Bijay Mohapatra on Monday (Sept 27).

Video Icon
COVAXIN
Covaxin May Get WHO Approval By Month-End, Says NITI Aayog

Covaxin may soon receive Emergency Use Listing by the World Health Organisation (WHO), eventually enabling its recipients to travel abroad without mandatory quarantine, NITI Aayog's Member, Health, V.K. Paul said on Wednesday.

Health Min Releases 1st Commercial Batch Of Covaxin From Bharat Biotech's New Plant
Health Min Releases 1st Commercial Batch Of Covaxin From Bharat Biotech's New Plant

India's vaccination coverage against coronavirus under the mass vaccination drive has crossed the landmark of 63 crore. Over 73 lakh doses have been administered in the last 24 hours.

Covaxin Single-Dose To Covid Infected Equivalent To 2 Doses For Unaffected: ICMR
Covaxin Single-Dose To Covid Infected Equivalent To 2 Doses For Unaffected: ICMR

The antibody responses of individuals with confirmed pre-vaccination SARS-CoV-2 infection were compared with those individuals without prior evidence of infection.

COVID Vaccine
India May Have COVID19 Vaccines For Children By September Or Just After It: ICMR-NIV

The results of Phase II and III trials of COVAXIN are going on for children in the age group of 2-18 years. So, by September or just after it, we may have COVID-19 vaccines for children, said Priya Abraham, Director of ICMR-NIV

Financial Aid Provided For Covaxin, Covishield Trials, Not R&D: Centre To SC
Covishield, Covaxin Combination Brings Better Immunogenicity Than 2 Doses Of Same Vaccine: ICMR

These findings have an important implication for the COVID-19 vaccination program wherein heterologous immunisation will pave the way for induction of improved and better protection against the variant strains of SARS-CoV-2.

Financial Aid Provided For Covaxin, Covishield Trials, Not R&D: Centre To SC
Monthly Production Capacity Of Covishield Projected To Increase To 120 Million Doses, Covaxin To 58 Million Doses

The Department of Biotechnology under the Ministry of Science and Technology has launched 'Mission COVID Suraksha- the Indian COVID-19 Vaccine Development Mission'.

 Covaxin
Indigenous COVID Vax Covaxin Effective Against Delta Plus Variant: ICMR

Delta Plus is a mutated form of the Delta variant and was first discovered in India. It is characterised by increased transmissibility and spike protein mutations.

scrollToTop